We evaluated the association between tobacco smoking and total cancer risk among Japanese populations based on a systematic review of epidemiological evidence. Methods: Original data were obtained from searches of MEDLINE using PubMed, complemented with manual searches. Evaluation of associations was based on the strength of evidence and the magnitude of association, together with biological plausibility as previously evaluated by the International Agency for Research on Cancer. Meta-analysis of associations was also conducted to obtain summary estimates of association. Results: A total of eight cohort studies were identified. In men, all studies consistently showed a moderately increased risk of total cancer in current smokers compared with never-smokers. In women, an increase in risk was seen but was weaker than in men. The summary relative risk was estimated as 1.53 (95% confidence interval 1.41-1.65). Conclusion: We conclude that there is convincing evidence that current tobacco smoking moderately increases the risk (1.5 times) of total cancer in the Japanese population compared with never-smoking Japanese.
INTRODUCTION
In Japan, lifestyle-related diseases such as cancer have been recognized as major components of the overall pattern of disease for decades, and the importance of the prevention of cancer by lifestyle modification is now strongly acknowledged. Various international and domestic guidelines and recommendations based on the epidemiological evidence for cancer prevention have appeared, with notable examples from the International Agency for Research on Cancer (IARC) (1), World Cancer Research Fund and American Institute for Cancer Research (2) , World Health Organization and Food and Agriculture Organization (WHO/FAO) (3) and Harvard Center for Cancer Prevention (4) . Evidence for these has for the most part been derived from Western populations, ensuring their suitability for these populations. Given that the host and environmental factors of Japanese populations are not always the same as those of the West, however, these guidelines may be incompletely relevant to Japanese. It is therefore important to evaluate the existing epidemiological evidence derived from Japanese populations, and from these derive relevant recommendations regarding major risk factors of cancer applicable to Japanese.
Our research group has investigated the association between health-related lifestyles and total cancers, as well as the five major cancer sites in Japan, namely the stomach, colon and rectum, liver, lung and breast. Findings were summarized and the magnitude of the effect of each lifestyle on cancer was assessed based on previous publications targeting Japanese populations. The present study focuses on the association between tobacco smoking and total cancer risk among Japanese populations.
METHODS
Original data for this review were identified by searches of MEDLINE using PubMed, complemented by manual searches of references from relevant articles where necessary. All epidemiological studies on the association between tobacco smoking and total cancer incidence or mortality among Japanese from 1966 to 2004, including papers in press if available, were identified using the search terms 'tobacco smoking', 'cancer', 'risk', 'cohort study', 'case-control study' and 'Japan' as keywords found in the abstract. Papers written in either English or Japanese were reviewed, and only studies on Japanese populations living in Japan were included. Individual results were summarized in the tables separately by study design as cohort or case-control studies.
Evaluation was made based on the strength of evidence and the magnitude of association. First, relative risks in each epidemiological study were grouped by magnitude of association, with consideration of statistical significance (SS) or no statistical significance (NS), as strong, <0.5 or >2.0 (SS); moderate, either (i) <0.5 or >2.0 (NS), (ii) >1.5-2 (SS) or (iii) 0.5 to <0.67 (SS); weak, either (i) >1.5-2 (NS), (ii) 0.5 to <0.67 (NS) or (iii) 0.67-1.5 (SS); or no association, 0.67-1.5 (NS). Criteria for the magnitude of association are summarized in Table 1 . After this process, overall magnitude of association was judged using the same criteria as for magnitude of association, together with the strength of evidence in a similar manner to that used in the WHO/FAO Expert Consultation Report (3), in which evidence was classified as 'convincing', 'probable', 'possible' and 'insufficient' ( Table 2) . We assumed that biological plausibility corresponded to the judgment of the most recent evaluation from the IARC (1) . Notwithstanding the use of this quantitative assessment rule, arbitrary assessment cannot be avoided when there is considerable variation in the magnitude of association between the results of each study. The final judgment, therefore, is made based on the consensus of research group members, and is not necessarily objective.
In addition, when there was 'convincing' or 'probable' evidence of a positive or inverse association, meta-analysis was conducted to obtain summary estimates of the association. In general, studies which reported relative risks and their confidence intervals (CIs) by comparing current smokers with never-smokers were included in the meta-analysis, but for those which categorized risk values separately according to smoking amount, such as the number of cigarettes smoked or pack-year index, meta-analysis was conducted to estimate summary risk values for current smokers, and these values were then used for further meta-analysis. In the case of multiple publication of analyses of the same or overlapping data sets, only data from the largest or most updated results were included, and incidence was given priority over mortality as an outcome measure. Incidence was also given priority in single publications describing both incidence and mortality. Studies without information on CIs and different reference categories were excluded from meta-analysis. General variance-based methods were used to estimate summary statistics and their 95% CIs. Heterogeneity among studies was examined by testing the Q statistic, with the model used to determine summary relative risk and its 95% CI, namely a random or fixed effect model, selected according to the statistical significance in the Q statistic. Meta-analysis was done using the meta command of STATA statistical package version 8 (13). 
Probable
Evidence based on epidemiological studies showing fairly consistent associations between exposure and disease, but where perceived shortcomings in the available evidence or some evidence to the contrary preclude a more definite judgment. Shortcomings in the evidence may be any of the following: insufficient duration of studies; insufficient studies available; inadequate sample sizes; or incomplete follow-up. Laboratory evidence is usually supportive, and the association should be biologically plausible.
Possible Evidence based mainly on findings from case-control and cross-sectional studies. Insufficient observational studies are available. Evidence based on non-epidemiological studies, such as clinical and laboratory investigations, is supportive. More studies are required to support the tentative associations, which should also be biologically plausible.
Insufficient
Evidence based on findings of a few studies which are suggestive, but are insufficient to establish an association between exposure and disease. More well-designed research is required to support the tentative associations.
*Criteria for the strength of evidence are based on those used in the Report of a Joint WHO/FAO Expert Consultation (3). Ex-smoker 
MAIN FEATURES AND COMMENTS
A total of eight cohort studies were identified (Table 3) . Among them, four presented results by gender (7, 9, 11, 12) , one for men only (5), and one for men and women combined only (8) . No case-control studies of the association between tobacco smoking and total cancer risk were identified. After excluding two studies due to the unavailability of a point estimate or CIs (6, 9) and one due to a shorter study analysis period than another study of the same population (10), four results for men, three for women and one for men and women combined were available for further evaluation. A summary of the magnitude of association for these studies is shown in Table 4 . In men, all studies consistently showed a moderately increased risk ("") of total cancer in current smokers compared with never-smokers. The study with men and women combined also showed moderately increased risk. The increase in risk in women was weaker than that in men,
